Knowledge of the rate of development of immature cardiomyocytes after implantation into a host heart is important for studies using cell therapy. To assess this functionally, we have implanted rat neonatal cardiomyocytes (NCMs) in normal and infarcted rat heart and re-isolated them for functional assessment. Maturation of implanted bone marrow stromal cells (BMSCs) was compared under similar conditions. NCMs from green fl uorescent protein (GFP) transgenic rats were implanted into adult normal or infarcted rat hearts and re-isolated after 1, 2, or 4 weeks by standard enzymatic digestion. BMSCs labeled with DiI and iron oxide were implanted into rats with myocardial infarction and cells re-isolated 1, 2, 5, 6, and 16 weeks later. GFP-labeled myocytes approaching the adult morphology were detected 2 weeks after implantation of NCMs, but were signifi cantly shorter than adult host myocytes and had reduced contractility. By 4 weeks after implantation, re-isolated GFP-labeled myocytes were close to the adult phenotype in contractile characteristics, although still signifi cantly shorter. Infarction of the host did not alter the rate of maturation of implanted cells. After implantation of BMSCs, small numbers of functional DiI-labeled myocytes were re-isolated from 4/11 animals but were more mature than expected from the NCM studies. This adds evidence that BMSC-derived cardiomyocytes were not a result of transdifferentiation. The maturation rate of implanted NCMs represents a benchmark against which to evaluate the likely rate of formation of fully functional cardiomyocytes from implanted cells.
Introduction
C ell therapy for cardiac disease is being intensively investigated, and promising results are being obtained with a number of stem cell sources both in animal studies and in clinical trials [ 1 , 2 ] . Bone marrow-derived stem cells are probably the most widely used in the clinical setting, and the partial success of early trials is likely to lead to larger and more numerous studies [ 3 ] . Regeneration of contractile muscle is a key goal, but different stem cells vary considerably in their ability to produce new cardiomyocytes. Early experiments where fetal cardiomyocytes from mice formed stable grafts in syngenic hosts were the proof of concept that such grafting was possible [ 4 ] . Further studies showed the ability of neonatal cardiomyocytes (NCMs) to integrate and produce functional benefi t in rat models of myocardial infarction, although clearly these will not be suitable for clinical applications [5] [6] [7] . Taking this forward to potentially implantable cell types, it was shown that a purifi ed population of cardiomyocytes derived from mouse embryonic stem cells (ESCs) could similarly integrate into the dystrophic adult mouse heart [ 8 ] . ESC [9] [10] [11] and adult cardiosphere-derived cells [ 12 ] have both been implanted into infarcted hearts after differentiation into immature myocytes, and have produced a functional improvement. However, the presence of immature myocytes within mature ventricle may not be entirely benign, since there are features of these cells which would be predicted to disrupt normal ventricular function. First, they often have spontaneous electrical and contractile activity: this is certainly true of ESC and authentic neonatal myocytes. Studies designed to procedure was as described below, and 0.7-3 × 10 6 cells were implanted in the border zone following occlusion.
Re-isolation and identifi cation of neonatal myocytes
Administrated NCMs were re-isolated 1, 2, and 4 weeks after cell transplantation by previously used methods [ 22 ] . Postnatal cardiomyocytes were also isolated from 2-to 4-week-old Sprague-Dawley (SD) rats in the same manner. In brief, hearts were retrogradely Langendorff-perfused with a low calcium (LC) solution (in mM/L: 120 NaCl, 5.4 KCl, 5 MgSO 4 , 5 sodium pyruvate, 20 glucose, 20 taurine, 10 HEPES, and 5 nitrilotriacetic acid (NTA); 12 μmol/L Ca 2+ ; pH 6.95; pre-oxygenated with 100% O 2 ) for 5 min. This was followed by recirculation perfusion with 1 mg/mL collagenase (Worthington, Lorne Laboratories, Twyford, UK) suspended in the LC solution without NTA, and with 200 μM Ca 2+ (pH 7.4). Heart tissues were chopped and shaken under 100% O 2 in collagenase. Detection of myocytes with GFP expression was by fl uorescence microscopy with 485 nm (excitation wave length) and 520 nm (emission).
Measurement of cellular contractile function
Isolated myocytes were placed into a 200 μL perspex fl ow bath with a cover glass fl oor on the stage of inverted microscope (Nikon Corp., Japan). Cells were superfused with oxygenated Krebs-Henseleit (K-H) solution of the following composition: (in mM/L: 119 NaCl, 4.7 KCl, 0.94 MgSO 4 , 1.2 KH 2 PO 2 , 25 NaHCO 3 , 11.5 glucose, 2 CaCl 2 ) equilibrated to pH 7.4, gassed with 95% O 2 /5% CO 2 at 2 mL/min at 37°C, and electrically stimulated with biphasic pulse (0.5 Hz, 50 mV, and 0.1-0.5 ms) via platinum electrodes along the sides of the chamber. Contraction amplitude (% shortening with each beat), rates of contraction, time-to-peak contraction (TTP), time-to-50% relaxation (R50), and time-to-90% relaxation (R90) were measured digitally using a video-edge detection system and data acquisition software (IonOptix Corp., Milton, MA). Data acquisition was started at least 10 min after electrically stimulating cells or after contraction amplitude had stabilized.
Labeling of BMSCs
BMSCs were harvested as reported by Alhadlaq and Mao [ 23 ] from either normal or GFP-transgenic rats and prepared as previously described [ 24 ] . BMSCs were incubated with 1 μL/mL DiI cell tracker dye (Molecular Probes, Invitrogen Ltd., Paisley, UK) as per manufacturer's instructions. In brief, cells were incubated with DiI for 5 min at 37°C followed by 15 min at 4°C, washed and fresh media was added. BMSCs were labeled overnight with micron-sized particles of iron oxide (MPIO; 2 μL/cm 2 , encapsulated magnetic microspheres; Bangs Laboratories Inc., Fishers, IN) on the day prior to transplantation, resulting in ~95% of BMSCs internalizing ~60 iron oxide particles per cell. The MPIO consisted of 0.9 μm polystyrene beads containing 62% magnetite in a central core, with an inert polymer coating. Double-labeled BMSCs were trypsinized from culture by trypsin/EDTA for 5 min at 37°C. The cells were centrifuged, resuspended at 2 × 10 7 cells per milliliter in phosphate-buffered saline (PBS) at 4°C ready for the in vivo procedure.
use ESC as a biological pacemaker have shown the ability of very small numbers of beating cells to drive pig hearts [ 13 ] . Because of this, there is the potential for ectopic foci associated with implanted cells to produce arrhythmias in ventricular myocardium. Since spontaneously beating immature myocytes from most sources respond to catecholamines with an increase in rate, this risk is especially great in the context of the cardiac patient with high sympathetic drive. Second, immature myocytes have different characteristics of excitation-contraction coupling than adult due to underdevelopment of various ion channels and intracellular calcium stores [14] [15] [16] [17] . Implanted cells may produce a heterogeneous substrate in the ventricular myocardium, which will predispose to re-entrant circuits. It is therefore important to know how long the newly introduced myocytes will remain in the immature state.
In the present study, we investigate the rate of development of implanted neonatal rat cardiomyocytes in adult rat heart by re-isolating them after different periods and directly measuring their size and contractile behavior. Re-isolated cells are compared with adult myocytes, and with myocytes isolated from immature animals. This will represent a gold standard with which to estimate the maximal rate of maturation of stem cells from other sources, which either begin as immature myocytes or transdifferentiate into immature myocytes. As an example, we have re-isolated labeled bone marrow stromal cells (BMSCs) from infarcted rat hearts, since the ability of these cells to form authentic cardiomyocytes has been a particularly contentious issue. Much of the debate has resulted from potential ambiguities when using immunohistochemical methods to identify cells within tissue samples. The method used here, although still dependent on labeling, allows unequivocal identifi cation of re-isolated individual BMSC-derived myocytes and measurement of their function. We show that implanted neonatal myocytes take 4 or more weeks to approach maturity but that, with BMSCs, the labeled myocytes that were observed appeared to have undergone more rapid development.
Materials and Methods
All animal experiments were performed under Home Offi ce-approved licenses at Imperial College London or Oxford University.
Neonatal cardiomyocyte labeling and implantation
NCMs were isolated from 1-to 3-day-old green fl uorescent protein (GFP) transgenic rats (CZ004 or SD-Tg(GFP)2BalRcc). All CZ004 rats in the present study were kind gifts from Professor Okabe in Osaka University [ 18 ] and SD-Tg(GFP)2BalRcc were from the Rat Resource and Research Centre, MO. The rats were killed by cervical dislocation. Ventricular myocytes were isolated by a method modifi ed from that of Iwaki et al. [ 19 ] and described previously [ 20 ] . Purifi ed NCMs were kept in the incubator at 37°C until in vivo cell transplantation into the heart of adult male nude rats ( rnu/rnu ) weighing 200-300 g. The 10
6 GFP-labeled NCMs in 100 μL culture medium were implanted into the apex of the recipient heart by direct intramyocardial injection with transient immobilization of the lower ventricle using a hemoclip, as previously described to improve adenoviral transfection [ 21 ] . For infarcted hearts, the infarction μM size range was counted in triplicate 200 μL aliquots at 40× magnifi cation on a Nikon TE 2000 microscope. The underside of the plates was exposed to a neodymium-ironboron magnet (6 mm diameter, 0.3 T, Maplin, UK) for 1 min to precipitate the BMSCs. Myocyte pellets were washed twice by centrifugation at 600 g in LC medium (above) and the number of fl uorescent rod-shaped cells above 30 μm in length counted in a similar manner. The total number of myocytes per milliliter was calculated using a hemocytometer. Photographs in fl uorescent and bright fi eld were taken for fl uorescing myocytes at 40×, with characteristic sarcomere striations confi rming their identity, and used to measure the lengths of ≥15 cells. When fl uorescent cells were observed, preparations were placed into the Perspex fl ow bath described above for contraction measurements.
Statistical methods
Data are displayed as mean ± standard error of the mean (SEM), except where indicated in Figure 1 . Differences
Infarction model and BMSC transplantation
This was as described previously using either SD or rnu/ rnu rats [ 24 ] . In brief, a thoracotomy was performed under isofl uorane anesthesia at the fourth intercostal space to expose the left upper surface of the heart. The left anterior descending coronary artery (LAD) was ligated at ~2 mm distal from the origin using 5-0 proline suture. Ten minutes after occlusion 4, 12.5 μL injections of a total of 2 × 10 6 BMSCs were performed into the border zone of the infarction area using 27-gauge needle. In 3 animals, 2 × 10 6 BMSCs were injected via a tail vein 1 day after infarction. Animals were sacrifi ced and cells isolated at 1, 2, 5, 6, and 16 weeks.
Re-isolation of BMSC/BMSC-derived cardiomyocytes
Hearts were digested as described above. BMSCs or myocytes derived from BMSCs were identifi ed from the red emissions from the DiI (excitation 510-560 nm, emission > 590 nm). The number of round fl uorescent cells in the 10-30 
FIG. 1.
Characteristics of labeled (red fl uorescent) and unlabeled (nonfl uorescent) myocytes isolated from rat heart 2 and 6 weeks after implantation of red DiI-labeled bone marrow-derived stromal cells. The n values for myocytes (from a single heart in each case) are shown under the columns: those for time-to-peak contraction (TTP), time-to-50% relaxation (R50), and time-to-90% relaxation (R90) are the same as those for contraction amplitude (% shortening).
Values are mean ± standard error of the mean (SEM) except for cell length: because of the large number of myocytes in the unlabeled 6 week group it is more appropriate to display data as mean ± standard deviation (SD), and therefore all length values in this fi gure are displayed in the same way. There is no signifi cant difference between labeled and unlabeled cells for any parameter.
length signifi cantly increased in direct proportion to the postnatal period ( Fig. 2A and Table 1 ), although by a smaller proportion than the doubling of heart weight in this time period (HW; 2-week-old 0.18 ± 0.01 g vs. 4-week-old 0.32 ± 0.01 g; P < 0.01). Basal amplitude (% shortening) showed no signifi cant difference among 2-week-old, 4-week-old, and adult cardiomyocytes ( Fig. 2B and Table 1 ). In contrast, R50 of 2-week-old rats was signifi cantly longer than other 2 groups, whereas there was no signifi cant difference between 4-week-old and adult rats ( Fig. 2C and Table 1 ). Contraction amplitude and relaxation parameters of adult myocytes from the GFP-transgenic rats (CZ004) did not differ significantly from those of the SD rats (GFP-TG: % shortening; 4.8% ± 0.9%, R50; 28 ± 1 ms, n = 8).
Morphological and functional development of GFP-positive neonatal cardiomyocytes after cell transplantation and re-isolation
Isolation of myocytes 2 weeks after implantation of GFPNCMs (2-week cell transplant, 2W CT) showed that the majority of re-isolated GFP-positive cells displayed the rodshaped cardiomyocyte phenotype with clear sarcomeres (eg, Fig. 3A ), although some remained amorphous. No such GFPpositive rod-shaped cells were observed at 1 week. Both viable rod-shaped myocytes (which were elongated and displayed good sarcomeric structure) and hypercontracted round myocytes were observed in all preparations. The cell length of GFP-positive cardiomyocytes at 2 weeks ranged from 35 to 76 μm, but on average was signifi cantly increased compared to the diameter of the original cultured NCMs in vitro (GFPNCMs: 11 ± 1 μm, n = 14; P < 0.001) but signifi cantly smaller than adult ( Fig. 4A ) . After 4 weeks (4W CT), morphological development of re-isolated GFP-NCMs was much clearer. Some were very similar to recipient cardiomyocytes but on average were still shorter than adult ( Figs. 3B and 4A and Table 1 ). GFP-positive myocytes were also evident in tissue sections ( Fig. 3C ) , and formed >1% of total isolated myocytes. Lengths of re-isolated GFP-NCMs after 2 and 4 weeks ( Fig. 4A ) were not signifi cantly different to myocytes from 2-and 4-week-old animals ( Fig. 2A ) , respectively.
Contraction amplitude was signifi cantly smaller in reisolated GFP-NCMs than cells from the recipient hearts in 2W CT, but there was no signifi cant difference between reisolated GFP-NCMs of 2W CT and 4W CT, or between adult and 4W CT ( Fig. 4B ) . Relaxation time (R50) was prolonged in 2W CT compared to 4W CT and to recipient cardiomyocytes, but again there was no difference between 4W CT and adult ( Fig. 4C and Table 1 ). Spontaneous beating was not seen in the re-isolated NCMs at 2 or 4 weeks.
Effect of myocardial infarction on rate of maturation of implanted GFP-positive neonatal cardiomyocytes
GFP-NCMs were implanted at the time of infarct, and isolations were again performed after 2 and 4 weeks. The main effect of infarction was to severely reduce the number of GFP-positive cardiomyocytes retrieved from >1% to ~0.01% when injected numbers were 0.7-1 × 10 6 neonates and ~0.05% with 3 × 10 6 neonates. Rates of development in reisolated GFP-positive cells were similar to those in non-infarcted hearts ( Fig. 5 and Table 1 ) with lengths signifi cantly between 2 groups were compared using Student's t -test, and for 3 groups one-way ANOVA was used, with Tukey's posttest comparing all columns. Values of P < 0.05 were considered signifi cant.
Results

Postnatal development and growth of rat cardiomyocytes
Postnatal isolated cardiomyocytes from SD rats at 2 and 4 weeks of age showed a similar rod-shaped morphology to the adult (6 weeks or older) myocytes, but were signifi cantly smaller than the adult length of 99 ± 9 μm ( Fig. 2A ) . The prohibitively long. For the other 2 preparations, 1 at 2 and 1 at 6 weeks, data were obtained from labeled and non-labeled myocytes in the same bath, although numbers were necessarily low. Cell lengths, contraction amplitude, and R50 values for these preparations are shown in Figure 1 and Table 1 . Cell lengths for the labeled myocytes were not signifi cantly different from unlabeled (or from the adult cells shown in Figs. 2 and 4 ), nor were parameters of contraction signifi cantly different between unlabeled and labeled myocytes for amplitude, TTP, or R50 or R90. Interestingly, labeled myocytes could not be concentrated using the magnet, unlike the BMSCs. To determine whether the effect might have been dependent on the DiI label, a further cohort was implanted with GFPpositive BMSCs from GFP-transgenic rats. No GFP-positive cardiomyocytes were found from 7 animals at 2 weeks after isolation: an average of 3.43 ± 0.95 × 10 5 rod-shaped cardiomyocytes was examined for each animal. All these animals had identifi able remaining BMSCs. In a separate series of experiments, no GFP-positive cardiomyocytes were obtained from 5 infarcted rats (cell implantation at 4 weeks after infarction) after GFP-positive BMC implantation (data not shown).
Discussion
This study defi nes the maturation process that occurs in transplanted cardiomyocytes, and shows that development from the neonatal stage to a phenotype which approaches (but is not identical to) the adult takes at least 4 weeks. It parallels closely the development time in the native rat heart from the immediate postnatal period until 4 weeks of age. Not surprisingly, transplantation into the cardiac environment stimulates the maturation process far more effi ciently than maintenance of the neonatal cells in culture. Transplant into the hostile environment of the infarcted heart reduces survival of the cells, but does not affect the maturation rate. Cardiomyocytes labeled with DiI were identifi ed in some animals after implantation of DiI-labeled BMSCs, and showed full contractile and morphological identity with the adult phenotype after 2 weeks.
shorter than adult at both 2 and 4 weeks, and R50 values signifi cantly longer at 2 but not 4 weeks. Contraction amplitudes were not signifi cantly different between groups. As might be predicted, the infarction had resulted in remodeling of the host myocytes, but it did not affect the implanted NCM development. Native adult myocytes of the infarcted animals differed from those of normal rats, being about 20% longer on average ( P < 0.05), and with a prolonged R50 (28 ± 2 ms normal, n = 9; 34 ± 2, n = 21, P < 0.0001). However, there were no differences in the implanted/re-isolated GFPpositive cells from infarcted compared with those isolated from normal rats in length or R50 ( Table 1 ) .
Morphological development of re-isolated BMSCs
BMSCs were detected from the DiI label in 11 of 11 rats, 1-16 weeks after implantation. Up to 30,000 cells (1.5%) from an original 2 × 10 6 were found, although counts were approximate because of large concentrations of BMSCs detected in the undigested scar. Their identity was further confi rmed by the observation that they were concentrated using a magnet placed on the underside of the plate. Our previous work had shown the presence of iron oxide-containing cells in the in vivo hearts using MRI up to 16 weeks after iron oxidelabeled BMSC implantation [ 24 ] . Rod-shaped, striated, cardiomyocytes displaying DiI fl uorescence were detected in 4 of 11 preparations (examples in Fig. 6 ). Fluorescently labeled (red) myocytes were seen in 1 preparation at 2 weeks Signifi cantly different from 2 week * P < 0.05, ** P < 0.01, *** P < 0.001; from 4 week # P < 0.05, ## P < 0.01, ### P < 0.001. n is number of cells: numbers of hearts are shown in fi gures.
Abbreviations: BMSC, bone marrow stromal cell; R50, time-to-50% relaxation.
before the age of 4 months [ 26 ] . In the rat, as in humans, myocyte cell number increases 3-4-fold from birth to 2 months of age [ 27 , 28 ] . This accounts for the greater proportional increase in rat heart weight/body weight ratio compared to myocyte size. In terms of function, contraction amplitude, expressed as % shortening, was not signifi cantly lower than the adult at 4 weeks in either native postnatal myocytes or implanted/ re-isolated NCMs, although the shorter length must produce a smaller contraction in absolute (μm) terms. Similar
The parameters chosen to characterize maturation of the myocytes were somewhat limited by the low numbers of re-isolated labeled cells to be studied, but encompassed the main morphological and functional criteria. Numbers of NCM retrieved were in line with previous studies where the survival rate of implanted NCMs rapidly decreased within 24 h after cell transplantation and was ~1%-10% after 1 week [ 5 ] . Cell length was the slowest parameter to develop, with average length signifi cantly shorter than adult at 4 weeks in both native postnatal myocytes and implanted/re-isolated NCMs. Cardiac growth and morphological development is composed of cellular proliferation and an increase in cellular volume [ 25 ] . The newborn human heart is thought to contain about half the total number of myocytes present in the adult heart and the adult values are reached probably and T-type). SR is not morphologically detected and no Ca 2+ sparks are observed [ 15 ] . In the neonatal period Ca 2+ sparks are observed, but development of both t-tubular structure and dyad connections between these and the SR change spark localization over the earlier weeks of development [ 16 ] . Maturation of the SR with increasing age is supported by observations that the decay of Ca 2+ transient was slower in neonatal cells than adult cells [ 15 ] and that thapsigargin or ryanodine, which pharmacologically inhibit SR Ca 2+ uptake or release respectively, had little effect on the contraction of fetal cardiomyocytes and NCMs [ 30 ] . This translates into a poorer contractile phenotype, with relaxation times particularly being slowed in immature myocytes. Relaxation times of implanted myocytes accelerate with time, but are still slow compared to adult at 4 weeks.
Overall our fi ndings for length, contraction, and relaxation show that implanted neonatal myocytes mature at rates commensurate with their normal growth processes in the host heart: this is around 4 weeks for rat but would be predicted to be longer in human heart, where gestational times are greater. Undifferentiated stem cells that have become cardiomyocytes, whether bone marrow-derived, embryonic, or native cardiac progenitor cells, have all been observed to develop fi rst into an immature form [ 31 , 32 ] . If implanted in the undifferentiated form, there must necessarily be an additional time period while cardiomyocyte differentiation occurs: for ESC in culture, this is in the region of 8-10 days [ 33 ] . The presence of immature cardiomyocytes within the myocardium represents a time of vulnerability in terms of arrhythmia generation. Both the spontaneous contractile activity of the immature cells and the mismatch between excitation-contraction coupling of mature and immature myocardium could be destabilizing factors. The potential for even small numbers of spontaneously active ESC-derived cardiomyocytes to stimulate the whole ventricle has been demonstrated in experiments aimed at producing new pacemakers [ 34 , 35 ] . The experiments described here suggest that spontaneous contractile activity is quickly lost as implanted cells mature, but we have observed a tendency for β-AR stimulation to induce arrhythmias at lower concentrations in reisolated immature myocytes (data not shown). The electrical heterogeneity introduced by skeletal myoblasts, whether or not they form connections with host myocardium [ 36 ] , has shown arrhythmogenic potential in both animals and man [ 37 , 38 ] . The presence of areas of immature cardiomyocytes, values were obtained for the postnatal and implanted/reisolated cells at either 2-or 4-week time points. R50 was signifi cantly longer than adult at 2 weeks, but had reached the adult value by 4 weeks: again, this was true for either native postnatal myocytes or implanted/re-isolated NCMs. This is in agreement with 2 previous comparative studies of contractility between adult and neonatal rat cardiomyocytes, where prolonged times to peak contraction and to relaxation were observed [ 14 , 29 ] . The immature phenotype is most distinctive in fetal cardiomyocytes, where the majority of Ca 2+ required to produce contraction is derived from Ca 
FIG. 6.
Example of an adult myocyte labeled with red fl uorescence re-isolated from a rat heart 2 weeks after implantation of red DiI-labeled bone marrow-derived stromal cells. Right, bright fi eld and left, fl uorescent image. Both viable rod-shaped myocytes (which were elongated and displayed good sarcomeric structure) and hypercontracted round myocytes were observed in all preparations.
in which contraction and relaxation are relatively poor, must remain a concern in terms of the generation of an arrhythmic substrate. Bone marrow-derived cells have been used in a fi rst generation of clinical trials that have shown feasibility and safety and some variable benefi t in terms of cardiac function [39] [40] [41] . Much controversy has been generated regarding the potential mechanism of benefi t. An initial study [ 42 ] demonstrated that BMSCs transdifferentiate into cardiomyocytes after cell transplantation into the infarcted myocardium. The BMSC-derived cells in the myocardium expressed the myocyte enhancer factor 2 (MEF2), the cardiac-specifi c transcription factor GATA-4, and the early marker of myocyte development Csx/Nkx2.5 [ 42 ] . A more detailed study has used a number of sophisticated methods to detect and characterize BMSC-derived cardiomyocytes within the heart [ 43 ] . However, this fi nding has been debated at length and challenged by other studies [ 44 , 45 ] . Our fi ndings are in keeping with the general consensus in the literature [ 46 ] , in that we have detected myocytes of the adult phenotype apparently derived from BMSCs, although at a low level. Labeled cardiomyocytes were found when red DiI was used, but GFP-positive cardiomyocytes were not observed after implantation of BMSCs from GFP rats. However, GFP can be less evident as a label against the autofl uorescent background of the native cardiomyocytes. It is also possible that the presence of GFP might alter the progenitor pool in BMSCs, or their propensity to transdifferentiate.
Important new information that comes from the re-isolation technique is that DiI-labeled BMSC-derived myocytes were not distinguishable from adult in size and contraction characteristics at 2 weeks, in contrast to the fi ndings with authentic implanted neonatal myocytes. Notably, mature appearance of bone marrow-derived cardiomyocytes within 9 days of implantation was also seen in the immunohistochemical study [ 42 ] . The phenotype of the BMSC-derived myocytes studied here is inconsistent with transdifferentiation followed by maturation, which would be expected to lead to a longer period of immaturity of BMSC-derived cardiomyocytes. We are left with the need to explain the sudden appearance of this small population of BMSC-derived adult cardiomyocytes. One possibility is transfer dye from BMSCs to host myocytes by mechanisms such as uptake of apoptotic fragments [ 47 ] . It was noticeable that the labeled myocytes did not appear to contain iron oxide, since they were not attracted to the magnet, but the larger mass of the cardiac myocyte may have confounded these observations. Alternatively, evidence has been accumulating for cell fusion as a genuine mechanism for the appearance of BMSC-derived cardiomyocytes, and our fi ndings would also be consistent with this hypothesis [ 44 , 48-50 ] .
In summary we have examined, for the fi rst time, implanted cells that have matured into cardiomyocytes within the host heart and then been re-isolated. This gives an unequivocal identifi cation of the labeled cells as authentic cardiomyocytes, and allows precise measurement of their contractile phenotype. We have established a time course of maturation for implanted differentiated immature cardiomyocytes, and shown that it parallels closely the normal duration of development. In this context, we have shown that BMSC-derived cardiomyocytes appear infrequently and undergo disproportionately rapid development.
